{"id":"exposure-to-triptan","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Drowsiness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Triptans bind to serotonin receptors, specifically the 5-HT1B and 5-HT1D receptors, which are located on the smooth muscle cells of blood vessels in the brain. This binding causes the blood vessels to constrict, which in turn reduces the inflammation and pain associated with migraines.","oneSentence":"Triptans are a class of drugs that work by stimulating serotonin receptors in the brain, leading to the dilation of blood vessels and the relief of migraine symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:53:06.264Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute treatment of migraine attacks with or without aura"},{"name":"Cluster headache"}]},"trialDetails":[{"nctId":"NCT07336277","phase":"PHASE3","title":"Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"Orthopedic Trauma, Sleep Quality","enrollment":30},{"nctId":"NCT07332143","phase":"PHASE2","title":"Psilocybin-Assisted Randomized Therapy","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"PTSD","enrollment":150},{"nctId":"NCT06910345","phase":"NA","title":"Effect of Melatonin Patches on Sleep in Urological Surgery","status":"COMPLETED","sponsor":"Atlas University","startDate":"2024-02-25","conditions":"Urological Surgery","enrollment":60},{"nctId":"NCT04501653","phase":"EARLY_PHASE1","title":"Precision Functional Brain Mapping in Psilocybin","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-06-01","conditions":"Psilocybin","enrollment":11},{"nctId":"NCT06407635","phase":"PHASE1","title":"A Study of Psilocybin for PTSD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-06-07","conditions":"Post Traumatic Stress Disorder","enrollment":20},{"nctId":"NCT07013565","phase":"PHASE2","title":"Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"New York Medical College","startDate":"2025-08-07","conditions":"Anaplastic Large Cell Lymphoma, ALK-Positive","enrollment":20},{"nctId":"NCT06816667","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety","status":"COMPLETED","sponsor":"Biomind Labs Inc.","startDate":"2024-10-21","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT04313712","phase":"","title":"Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2021-11-15","conditions":"Blast or Combat Exposure, Head Injury Trauma","enrollment":30},{"nctId":"NCT03154567","phase":"PHASE1","title":"Effects of Stress and Drug-cue Exposure (SCM)","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2017-11-01","conditions":"Marijuana Abuse","enrollment":12},{"nctId":"NCT04141501","phase":"PHASE2","title":"Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2020-06-08","conditions":"Alcohol Use Disorder","enrollment":37},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT00911053","phase":"NA","title":"Melatonin for Circadian Sleep Disorders in the Blind","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"1997-06","conditions":"Insomnia, Blindness, Daytime Sleepiness","enrollment":59},{"nctId":"NCT01031979","phase":"PHASE2","title":"Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2010-12-01","conditions":"Post-Traumatic Stress Disorder","enrollment":26},{"nctId":"NCT00875784","phase":"PHASE1","title":"An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-05-06","conditions":"Migraine Disorders","enrollment":30},{"nctId":"NCT01153802","phase":"PHASE1","title":"An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-04-03","conditions":"Depressive Disorder","enrollment":12},{"nctId":"NCT02838537","phase":"","title":"TRiptan Use and Serious Vascular Events in Elderly Over 65 Years","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2015-11","conditions":"Migraine","enrollment":25000},{"nctId":"NCT01114373","phase":"PHASE2","title":"Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-06","conditions":"Hypertension","enrollment":40},{"nctId":"NCT01114360","phase":"PHASE2","title":"Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-03","conditions":"Hypertension","enrollment":37},{"nctId":"NCT01059604","phase":"","title":"Sumatriptan and Naratriptan Pregnancy Registry","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-12","conditions":"Migraine Disorders","enrollment":868},{"nctId":"NCT00387179","phase":"NA","title":"Effectiveness of Combining Light and Non-Light Treatments for Jet Lag and Sleep Disorders","status":"UNKNOWN","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2006-10","conditions":"Sleep Disorders, Circadian Rhythm","enrollment":48},{"nctId":"NCT00564590","phase":"PHASE1, PHASE2","title":"SThe Effects of Melatonin on GERD Symptoms","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2008-10","conditions":"Gastroesophageal Reflux Disease","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Exposure to Triptan","genericName":"Exposure to Triptan","companyName":"Assistance Publique Hopitaux De Marseille","companyId":"assistance-publique-hopitaux-de-marseille","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triptans are a class of drugs that work by stimulating serotonin receptors in the brain, leading to the dilation of blood vessels and the relief of migraine symptoms. Used for Acute treatment of migraine attacks with or without aura, Cluster headache.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}